Best Biotech Stock: Pfizer or Bristol-Myers?: Pfizer (NYSE: PFE) ,Bristol-Myers Squibb (NYSE: BMY)

The concept of a stock war couldn’t be simpler.
Pit two companies against one another, conduct a blow-by-blow fundamental comparison of each, and (based on the results) pinpoint the most investment-worthy stock.
We use our seven guiding principles of dividend investing – plus one more key factor – to determine the winner.
Armed with the analysis, you can then consider buying the champion – or both, if it’s a close matchup. This time, I’ll be pitting together two companies from the pharmaceutical sector: Pfizer (NYSE: PFE) and Bristol-Myers Squibb (NYSE: BMY).  (more)
Please share this article